Stepping into a new era of ophthalmology at EURETINA 2022


This year’s hybrid meeting will allow attendees to participate in person or virtually. Either way, this congress will offer a wealth of information to specialists covering all aspects of retinal diseases.

Stepping into a new era of ophthalmology at EURETINA 2022

The 2022 22nd European Society of Retina Specialists (EURETINA) Congress is slated for September 1 to 4 in the Congress Centre Hamburg, Hamburg, Germany.

This is a hybrid meeting that allows attendees to participate either in person or virtually. Either way, this congress offers a wealth of information to specialists covering all aspects of retinal diseases.

Alistair Laidlaw, EURETINA president and retinal surgeon at St. Thomas’ Hospital, London, and Maidstone Hospital, Kent, UK, is eagerly anticipating the conference.

“The program in Hamburg boasts a cutting-edge scientific program. With a choice of more than 100 EURETINA sessions, symposia, and instructional courses covering all subspecialty themes, there is something at EURETINA 22 for everyone,” he commented.

He also pointed out that with plans progressing rapidly for the first EURETINA FEBO Retina subspecialty examination, instructional courses targeting the core exam content will be offered.

Another new addition this year, a Saturday night EURETINA Party that is open to all delegates, is planned for Saturday evening.

EURETINA Main Meeting

There is no shortage of opportunities for educational enlightenment at this meeting.A look at the online program shows the depth from which clinicians can choose.

These offerings, in addition to Keynote Lectures and symposia enumerated below, include World Retina Day, which highlights advances in retinal care around the world; instructional courses; subspecialty sessions; free papers; the Speakers’ Corner; the wet lab program; and YOURS sessions, i.e., a symposium, science slam, and mystery cases.

Other EURETINA Highlights

Four Keynote Speeches are planned. The dates and times follow; all times are expressed as central European summer time (CEST).

Thursday, 1 September at 16:00 CEST: Dr Sobha Sivaprasad from Moorfields Hospital, London, will deliver the EURETINA Lecture titled “Steps to achieving the impossible in the clinical management of diabetic retinopathy.

Friday, 2 September at 09:45 CEST: Dr Enrico Borrelli from the San Raffaele Milan, will discuss the Ophthalmologica Lecture titled “Pushing retinal imaging forward: innovations and their clinical meaning.”

Saturday, 3 September at 12:30 CEST: Dr Catherine Creuzot-Garcher from University Hospital, Dijon, France, will deliver the Gisbert Richard Lecture titled “Macular surgery: outcomes and complications.”

Saturday, 3 September at 13:00 CEST: Dr Hiroko Terasaki from the Nagoya University Institutes of Innovation for Future Society, will deliver the Kreissig Award Lecture on “Retinal mobility and plasticity in retinal surgery.”

Satellite Symposia

The symposia and times scheduled for September 1-3 are as follows:

1 September 2022

Management of diabetic macular oedema: bridging the real-world efficacy gap: 13:15-14:15 CEST

2 September 2022

Recent Advances in Multimodal Imaging and Artificial Intelligence in Ophthalmology:13:15-14:15 CEST

Smaller, Faster, Closer - Precision in Retina Surgeries: 13:15-14:15 CEST

UWF Multimodal Imaging and Microperimetry: Enhancing the Bridge between Structure and Function: 13:15-14:15 CEST

Advancing the management of nAMD: Latest clinical insights from targeting Ang-2/VEGF-A via dual inhibition: 13.45 - 14.45 CEST

How LASER has changed since coronavirus struck?: 13.45 - 14.45 CEST

Reducing the burden of DME – what matters in effective clinical management?: 13.45 - 14.45 CEST

Benefits beyond vision: 10 years of delivering outcomes that matter: 13.45 - 14.45 CEST

Expert clinical insights: How continuous delivery of anti-VEGF is changing the management of nAMD: 17.45 - 18.45 CEST

3 September 2022

MicroPulse® and PASCAL® in the world of retinal treatments: 09.45 - 10.45 CEST

Durability across indications: Seeing from the patient's perspective: 09:45 - 10:45 CEST

A vision of the future: The next level in patient care: 13.45 - 14.45 CEST

Broadening management options for DME: Recent clinical insights from targeting dual inhibition of Ang-2 and VEGF-A: 13.45 - 14.45 CEST

Wide field swept source OCT: Learn from our experts!: 13.45 - 14.45 CEST

Preserving patient health: the retina and beyond: 13.45 - 14.45 CEST

Driving efficiency & performance through visionary technology: 13.45 - 14.45 CEST

Experience from the clinic: management of neovascular AMD patients in 2022: 13.45 - 14.45 CEST

Fine-Tune your Vitreoretinal Surgery – How to get the best view for you and your patients: 13.45 - 14.45 CEST

The Future of Geographic Atrophy: advancing diagnosis, treatment and management: 13.45 - 14.45 CEST

Member registration is currently open and can be accessed at

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.